Back to results
US 6,258,850 B1Granted
3-aryl-2-hydroxypropionic acid derivative (I)
AssigneeAstraZeneca AB
InventorKjell Andersson
Life of this patent
Estimating the term…
Abstract
A novel 3-aryl-2-hydroxypropionic acid derivative, a process and intermediate for its manufacture, pharmaceutical preparations containing it and the use of the compound in clinical conditions associated with insulin resistance.
Claims8
A compound having the formula
- or a pharmaceutically acceptable salt, solvate or crystalline form thereof.
(S)-2-Ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid.
Dependencies are inferred from the claim text.